Format

Send to

Choose Destination
Ann Rheum Dis. 2017 Jul;76(7):1263-1268. doi: 10.1136/annrheumdis-2016-210357. Epub 2017 Jan 16.

Cardiovascular risk of patients with gout seen at rheumatology clinics following a structured assessment.

Author information

1
Sección de Reumatología, Hospital General Universitario de Alicante, Alicante, Spain.
2
Departamento de Medicina Clínica, Universidad Miguel Hernández, Alicante, Spain.
3
Sección de Reumatología, Hospital General Universitario de Elda, Alicante, Spain.
4
Instituto de Salud Musculoesquelética, Madrid, Spain.

Abstract

OBJECTIVES:

Gout-associated cardiovascular (CV) risk relates to comorbidities and crystal-led inflammation. The aim was to estimate the CV risk by prediction tools in new patients with gout and to assess whether ultrasonographic carotid changes are present in patients without high CV risk.

METHODS:

Cross-sectional study. Consecutive new patients with crystal-proven gout underwent a structured CV consultation, including CV events, risk factors and two risk prediction tools-the Systematic COronary Evaluation (SCORE) and the Framingham Heart Study (FHS). CV risk was stratified according to current European guidelines. Carotid ultrasound (cUS) was performed in patients with less than very high CV risk. The presence of carotid plaques was studied depending on the SCORE and FHS by the area under the curve (AUC) of receiver operating curves.

RESULTS:

237 new patients with gout were recruited. CV stratification by scores showed a predominance of very high (95 patients, 40.1%) and moderate (72 patients, 30.5%) risk levels. cUS was performed in 142 patients, finding atheroma plaques in 66 (46.5%, 95% CI 37.8 to 54.2). Following cUS findings, patients classified as very high risk increased from 40.1% up to 67.9% (161/237 patients). SCORE and FHS predicted moderately (AUC 0.711 and 0.683, respectively) the presence of atheroma plaques at cUS.

CONCLUSIONS:

The majority of patients presenting with gout may be at very high CV risk, indicating the need for initiating optimal prevention strategies at this stage. Risk prediction tools appear to underestimate the presence of carotid plaque in patients with gout.

KEYWORDS:

Atherosclerosis; Cardiovascular Disease; Gout; Ultrasonography

PMID:
28093417
DOI:
10.1136/annrheumdis-2016-210357
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center